EP3042917
And-N3pGlu amýlóíð-beta-peptíðmótefni og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.8.2011EP published:
21.2.2018EP application number:
15196358.4
EP translation filed:
19.3.2018Grant published:
15.4.2018EPO information:
European Patent Register
Max expiry date:
8.8.2031Expiry date:
8.8.2026Next due date:
31.8.2026
Title:
ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
Timeline
Today
9.8.2011EP application
21.2.2018EP Publication
19.3.2018Translation submitted
15.4.2018Registration published
8.8.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
Demattos, RonaldAddress:
Indianapolis, Indiana, US
Name:
Lu, JirongAddress:
Indianapolis, Indiana, US
Name:
Tang, YingAddress:
Indianapolis, Indiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
373026 PDate:
12.8.2010Country:
US
Classification
Categories:
C07K 16/18, G01N 33/577, A61K 39/395, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 17.7.2018
Expires: 8.8.2019
Payer: Örn Þór, slf.
Number: 9
Paid: 15.7.2019
Expires: 8.8.2020
Payer: Örn Þór, slf.
Number: 10
Paid: 10.7.2020
Expires: 8.8.2021
Payer: Örn Þór slf.
Number: 11
Paid: 20.7.2021
Expires: 8.8.2022
Payer: Patice ehf.
Number: 12
Paid: 20.7.2022
Expires: 8.8.2023
Payer: Patice ehf.
Number: 13
Paid: 20.7.2023
Expires: 8.8.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.7.2024
Expires: 8.8.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.8.2025
Expires: 8.8.2026
Payer: Árnason Faktor ehf.